| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/10/2008 | WO2008081891A1 Orally disintegrating solid preparation |
| 07/10/2008 | WO2008081829A1 Aminoalkylmethacrylate copolymer e for maintaining solubility of poorly water-soluble drug |
| 07/10/2008 | WO2008081774A1 Orally disintegrating tablet and bitter-blocking preparation each comprising risperidone |
| 07/10/2008 | WO2008081686A1 Cholesterol derivative, liposome, method for forming liposome and contrast agent for x-ray |
| 07/10/2008 | WO2008081590A1 Medical composition |
| 07/10/2008 | WO2008081463A2 Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof |
| 07/10/2008 | WO2008081418A1 Glucagon-like protein-1 receptor (glp-1r) agonist compounds |
| 07/10/2008 | WO2008081255A1 Derivatives of acid polysaccharides |
| 07/10/2008 | WO2008081175A2 Method of producing a composition from an oleogel and an aqueous gel and the composition |
| 07/10/2008 | WO2008080773A1 Method for producing solid dosage forms containing graft copolymers |
| 07/10/2008 | WO2008080542A2 Combination product for controlling parasites on animals |
| 07/10/2008 | WO2008080541A1 Agents for controlling parasites on animals |
| 07/10/2008 | WO2008080369A1 Steady liposomal composition |
| 07/10/2008 | WO2008080367A1 Liposome formulation and process for preparation thereof |
| 07/10/2008 | WO2008080291A1 Poly(glutamic acid)-drug conjugate with an amino acid as a linker |
| 07/10/2008 | WO2008080218A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 07/10/2008 | WO2008060367A9 Human antibodies that bind cxcr4 and uses thereof |
| 07/10/2008 | WO2008054498A3 Hydrophilic polymer-conjugated lipids for peptide and protein folding disorders |
| 07/10/2008 | WO2008002691A3 A process for manufacturing a delivery system for active components as part of an edible composition |
| 07/10/2008 | WO2007120725A3 Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive |
| 07/10/2008 | WO2007066335A3 Methods for affecting liposome composition by ultrasound irradiation |
| 07/10/2008 | US20080167386 Anticarcinogenic and antiproliferative agents; drug screening; inhibiting Dvl-mediated Wnt signaling |
| 07/10/2008 | US20080167385 Crystal Structure of Human Proliferating Cell Nuclear Antigen (Pcna) and Uses Thereof |
| 07/10/2008 | US20080167370 Multidrug multiligand conjugates for targeted drug delivery |
| 07/10/2008 | US20080167365 Of the ACE inhibitor ramipril by mixing with the ramipril (m)ethyl ester prodrug and a pressure sensitive adhesive carrier; improved pharmacokinetics; sustained release |
| 07/10/2008 | US20080167280 Enhanced drug delivery in transdermal systems |
| 07/10/2008 | US20080167270 Anti-infective phosphonate analogs |
| 07/10/2008 | US20080167245 Novel metastasis suppressor gene on human chromosome 8 |
| 07/10/2008 | US20080167226 solution contains GLP-1(7-37) or an analogue wherein an amino acid residue of the parent peptide has a lipophilic substituent attached optionally via a spacer; pH is 7-10; stability, long shelf life; biodrug for stimulating insulin secretion, lowing blood glucose |
| 07/10/2008 | US20080166800 Method and medicament for inhibiting the expression of a given gene |
| 07/10/2008 | US20080166414 Delivery particles having surface altering agent; transfection efficiency |
| 07/10/2008 | US20080166413 Topical pharmaceutical formulations and methods of treatment |
| 07/10/2008 | US20080166409 Shape-retentive hydrogel particle aggregates and their uses |
| 07/10/2008 | US20080166406 Rapidly Disintegrating Dosage Form Comprising Magnesium Carbonate Heavy |
| 07/10/2008 | US20080166402 Medical Compositions for Intravesical Treatment of Bladder Cancer |
| 07/10/2008 | US20080166394 For reducing cancer risks |
| 07/10/2008 | US20080166391 Zero-order prolonged release coaxial implants |
| 07/10/2008 | US20080166390 For extracorporeal device for use in surgery; intraocular lenses |
| 07/10/2008 | US20080166389 Compositions and methods for treatment of hyperplasia |
| 07/10/2008 | US20080166387 Anti-angiogenic compositions and methods of use |
| 07/10/2008 | US20080166386 Glycolic acid-lactic acid copolymers as bulking agent; soft tissue augmentation |
| 07/10/2008 | US20080166381 Emulsifier Composition Based on Pentaerythritol Esters and Aloxylated Nonionic Emulsifiers |
| 07/10/2008 | US20080166380 Drug encapsulated polymer micelles formed from a block copolymer having a hydrophilic segment and hydrophobic segment, and has been subjected to high-pressure treatment; drug delivery |
| 07/10/2008 | US20080166365 Composition For Adjusting Water Quality For Adminstration Of Water Sanitizer Sensitive Medicaments Or Vaccines |
| 07/10/2008 | US20080166362 New effector conjugates, process for their production and their pharmaceutical use |
| 07/10/2008 | US20080166361 Monoclonal antibody conjugate for targeting 10-boron to tumor cells; boron neutron capture therapy |
| 07/10/2008 | US20080166346 Freeze dried monoclonal antibody specific for endothelial growth factor receptors for use treatment of cell proliferative disorders; enhanced storage stability |
| 07/10/2008 | US20080166311 Use of agglomerated hydroxyethylcellulose in pharmaceutical, personal care and household care applications |
| 07/10/2008 | US20080166300 Screening for agents that modulate a cancer associated phosphatase function; combining a candidate biologically active agent with a polypeptide having phosphatase activity; assessing the effectiveness on cancer cells |
| 07/10/2008 | US20080166294 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 07/10/2008 | US20080166293 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 07/10/2008 | CA2674671A1 Combination product for controlling parasites on animals |
| 07/10/2008 | CA2674669A1 Agents for controlling parasites on animals |
| 07/10/2008 | CA2674112A1 Glucagon-like protein-1 receptor (glp-1r) agonist compounds |
| 07/10/2008 | CA2674063A1 Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by administering a 19-nor containing vitamin d analog with or withouta retinoid |
| 07/10/2008 | CA2674007A1 Process for manufacturing vaccines |
| 07/10/2008 | CA2673976A1 Gel composition for treating mycosis |
| 07/10/2008 | CA2673959A1 Aminoalkyl methacrylate copolymer e for maintaining solubility of poorly-soluble drug |
| 07/10/2008 | CA2673947A1 Derivatives of acid polysaccharides |
| 07/10/2008 | CA2673924A1 Liposomal pharmaceutical preparation and method for manufacturing the same |
| 07/10/2008 | CA2673668A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 07/10/2008 | CA2672538A1 Pharmaceutical compositions of alkyl gallates |
| 07/10/2008 | CA2672021A1 Factor ix moiety-polymer conjugates having a releasable linkage |
| 07/09/2008 | EP1942130A2 Novel carbosilane dendrimers, preparation method thereof and use of same |
| 07/09/2008 | EP1942117A1 Derivatives of acid polysaccharides |
| 07/09/2008 | EP1941880A1 Lotion preparation containing pyridonecarboxylic acid derivative |
| 07/09/2008 | EP1941878A1 Sedative non-benzodiazepine formulations |
| 07/09/2008 | EP1941871A1 Formulations for prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
| 07/09/2008 | EP1941868A2 Improvements in or relating to the delivery of oral drugs |
| 07/09/2008 | EP1941862A1 Tablet for removal of tongue coating |
| 07/09/2008 | EP1940895A1 A oligomeric lactide macromer based copolymer and a process for the preparation thereof |
| 07/09/2008 | EP1940513A1 A nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle |
| 07/09/2008 | EP1940470A2 Antibody-drug conjugates and methods of use |
| 07/09/2008 | EP1940469A1 Animal medicament and method of manufature |
| 07/09/2008 | EP1940468A2 Bi-modal hyaluronate solution |
| 07/09/2008 | EP1940467A2 Sustained drug release composition |
| 07/09/2008 | EP1940464A1 Hexosylceramides as adjuvants and their uses in pharmaceutical compositions |
| 07/09/2008 | EP1940449A2 Wound-healing pharmaceutical compositions comprising at least one soluble dextran and at least one platelet-derived growth factor |
| 07/09/2008 | EP1940448A2 Pdgf amphiphilic polymer complex |
| 07/09/2008 | EP1940447A1 Treatment of neurodegenerative disorders |
| 07/09/2008 | EP1940444A2 Methods of preparing targeted immunoliposomes |
| 07/09/2008 | EP1940428A1 Bile preparations for gastrointestinal disorders |
| 07/09/2008 | EP1940414A2 Anti mineralocorticoid therapy of infection |
| 07/09/2008 | EP1940413A1 Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride |
| 07/09/2008 | EP1940391A1 Stabilized extended release pharmeceutical compositions comprising an hmg-coa reductase inhibitor |
| 07/09/2008 | EP1940364A2 Capsule formulation of pirfenidone and pharmaceutically acceptable excipients |
| 07/09/2008 | EP1940355A2 Drug delivery nanocarriers targeted by landscape phage |
| 07/09/2008 | EP1940353A2 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis |
| 07/09/2008 | EP1940352A1 Method of preparing an aqueous pharmaceutical composition comprising hydroxypropyl methylcellulose and pharmaceutical c0mp0siti0ns obtainable |
| 07/09/2008 | EP1940295A2 Resonant nanostructures and methods of use |
| 07/09/2008 | EP1755650B1 A biomolecule-containing suspension formulation of increased stability deliverable via an implantable delivery device |
| 07/09/2008 | EP1729794B1 A pharmaceutical composition comprising a non-detergent sulphobetaine |
| 07/09/2008 | EP1684730B1 Pharmaceutical composition having a cationic excipient |
| 07/09/2008 | EP1667727B1 Polyamine-metal chelator conjugates |
| 07/09/2008 | EP1578843B1 Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof |
| 07/09/2008 | EP1572226B1 Peptides having a high cysteine content |
| 07/09/2008 | EP1534070A4 Methods for treating fungal infections |
| 07/09/2008 | EP1492577B1 Film-forming compositions for protecting skin from body fluids and articles made therefrom |
| 07/09/2008 | EP1455756B1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 07/09/2008 | EP1427391B1 Solid-phase agent for vascular occlusion with immobilised platelet binding agent |